Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

FRANCESCO BOIN

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1417908229
CMS profile
830721
Location
WEST HOLLYWOOD, CA

General Payments · PY2019–2024

$27,052.14

  • Reported across 32 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$8,592.00

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Actelion Pharmaceuticals US, Inc. $8,592.00 13

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $586.45 2
PY2021 $7,020.00 6
PY2022 $3,507.72 2
PY2023 $7,345.97 9
PY2024 $8,592.00 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2019202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $518.56 04/01/2024 Travel and Lodging Undisputed 01/23/2026 1078873082 CMS
Actelion Pharmaceuticals US, Inc. $195.38 04/26/2024 Travel and Lodging Undisputed 01/23/2026 1078873052 CMS
Actelion Pharmaceuticals US, Inc. $150.00 04/26/2024 Food and Beverage Undisputed 01/23/2026 1078873054 CMS
Actelion Pharmaceuticals US, Inc. $60.00 04/27/2024 Food and Beverage Undisputed 01/23/2026 1078873050 CMS
Actelion Pharmaceuticals US, Inc. $40.00 04/27/2024 Food and Beverage Undisputed 01/23/2026 1078873056 CMS
Actelion Pharmaceuticals US, Inc. $20.00 04/27/2024 Food and Beverage Undisputed 01/23/2026 1078873060 CMS
Actelion Pharmaceuticals US, Inc. $20.00 04/27/2024 Food and Beverage Undisputed 01/23/2026 1078873062 CMS
Actelion Pharmaceuticals US, Inc. $14.05 04/30/2024 Food and Beverage Undisputed 01/23/2026 1078873048 CMS
Actelion Pharmaceuticals US, Inc. $70.93 04/30/2024 Travel and Lodging Undisputed 01/23/2026 1078873070 CMS
Actelion Pharmaceuticals US, Inc. $3,770.00 05/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1078873064 CMS
Actelion Pharmaceuticals US, Inc. $121.15 07/25/2024 Food and Beverage Undisputed 01/23/2026 1078873076 CMS
Actelion Pharmaceuticals US, Inc. $3,480.00 07/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1078873072 CMS
Actelion Pharmaceuticals US, Inc. $131.93 08/02/2024 Travel and Lodging Undisputed 01/23/2026 1078873066 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.